(Q46611107)

23 December 2017

title

Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene (English)

1 reference

23 December 2017

0 references

Daniela Di Bella

3

0 references

Giampaolo Perna

object named as

Giampaolo Perna

1

0 references

Laura Bellodi

5

object named as

Laura Bellodi

1 reference

23 December 2017

author name string

Elisa Favaron

2

1 reference

23 December 2017

Riccardo Bussi

4

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

23 December 2017

published in

Neuropsychopharmacology

1 reference

23 December 2017

volume

30

1 reference

23 December 2017

issue

12

1 reference

23 December 2017

page(s)

2230-2235

1 reference

23 December 2017

The family history method using diagnostic criteria. Reliability and validity

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

The Panic-Associated Symptom Scale: measuring the severity of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Neurosteroid secretion in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Functionally gene-linked polymorphic regions and genetically controlled neurotransmitters metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Serotonin, the periaqueductal gray and panic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Allelic Variation of Human Serotonin Transporter Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Brief standard self-rating for phobic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Predictors of serious suicide attempts among patients with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Menstrual cycle-related sensitivity to 35% CO2 in panic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Estrogen-induced panic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Neurosteroids in depression: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

The cross-national epidemiology of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

7 January 2021

Functional promoter polymorphism of the human serotonin transporter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

7 January 2021

Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

7 January 2021

A naturalistic 6-year follow-up study of patients with panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

7 January 2021

Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

7 January 2021

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

7 January 2021

A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300822

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300822

1 reference

23 December 2017

1 reference

23 December 2017